Related Experiment Videos
Overview. A new discovery phase for antitumor drugs?
1Department of Medicine, Virginia Commonwealth University/Medical College of Virginia, PO Box 980230, Richmond, VA, USA. gewirtz@hsc.vcu.edu
Current Opinion in Investigational Drugs (London, England : 2000)
|March 16, 2001
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
p53-Dependent accelerated senescence induced by ionizing radiation in breast tumour cells.
International journal of radiation biology·2005
Suppression of c-myc expression and c-Myc function in response to sustained DNA damage in MCF-7 breast tumor cells.
Biochemical pharmacology·2001
The vitamin D3 analog, ILX-23-7553, enhances the response to adriamycin and irradiation in MCF-7 breast tumor cells.
Cancer chemotherapy and pharmacology·2001
Rb dephosphorylation and suppression of E2F activity in human breast tumor cells exposed to a pharmacological concentration of estradiol.
Archives of biochemistry and biophysics·2001
Reporting disease control rates or clinical benefit rates in early clinical trials of anticancer agents: useful endpoint or hype?
Current opinion in investigational drugs (London, England : 2000)·2011
Abating progressive tissue injury and preserving function after CNS trauma: The role of inflammation modulatory therapies.
Current opinion in investigational drugs (London, England : 2000)·2010
Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis.
Current opinion in investigational drugs (London, England : 2000)·2010
Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD.
Current opinion in investigational drugs (London, England : 2000)·2010
Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease.
Current opinion in investigational drugs (London, England : 2000)·2010
Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema.
Current opinion in investigational drugs (London, England : 2000)·2010
Tolerability of [161Tb]Tb-SibuDAB in comparison to other PSMA-targeting radioligands in the preclinical setting.
European journal of nuclear medicine and molecular imaging·2026
Efficacy and safety of adjuvant CDK4/6 inhibitors in hormone receptor-positive, HER2-negative early breast cancer: Updated evidence from a systematic review and meta-analysis.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026
Decision-to-outcome analysis of multidisciplinary tumor board-managed NSCLC patients.
Turk gogus kalp damar cerrahisi dergisi·2026
Electronic Structure Engineering at C7 Position of Thieno-Cytosine (thC): Toward Optimal Probe-Adduct Interactions with ABPG in DNA.
The journal of physical chemistry. B·2026
How Functional Variants Reconfigure the Rac2 Conformational Landscape.
The journal of physical chemistry. B·2026